Shimizu T, Sands J, Yoh K, Spira A, et al. First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01. J Clin Oncol 2023 Jun 16:JCO2300059. doi: 10.1200/JCO.23.00059.
PMID: 37327461